Today: 3 July 2026
Browse Category

Stock Market 6 January 2026

Rolls-Royce (RR.L) hits new 52-week high after fresh buyback disclosure — what investors watch next

Rolls-Royce (RR.L) hits new 52-week high after fresh buyback disclosure — what investors watch next

London, January 6, 2026, 08:08 GMT — Regular session Rolls-Royce Holdings rose 1.2% to 1,246 pence in early London trade on Tuesday, touching a new 52-week high after the company disclosed further purchases under its £200 million share buyback. The jet-engine maker said it bought 458,730 shares on Monday at an average price of about 1,231 pence, taking total repurchases since the programme began to 934,612 shares. Investing.com
6 January 2026
·
BP stock watch: Tiber contract, buyback and oil slide put BP PLC shares in focus

BP stock watch: Tiber contract, buyback and oil slide put BP PLC shares in focus

London, Jan 6, 2026, 07:53 GMT — Premarket BP shares will be in focus at the London open on Tuesday after TechnipFMC said it won a $600 million-$800 million iEPCI contract — a bundled design-to-install offshore package — from BP for its high-pressure Tiber development in the Gulf of America. BP ended Monday down 0.6% at 435.25 pence. technipfmc.com+1
6 January 2026
···
1 … 882 883 884 885 886 … 1,613

Stock Market Today

  • Proteomics International (ASX: PIQ) Soars 28% on Friday as Investors React to Regulatory and Commercial Moves
    July 3, 2026, 12:16 AM EDT. Shares of Proteomics International Laboratories Ltd (ASX: PIQ) shot up 28.13% to AUD 0.20 on Friday after the company announced steps forward in its precision diagnostics and proteomics technology platform. The move comes as PIQ works on expanding its commercial footprint, securing regulatory clearances, and building up globally. The company said it's working to grow product adoption through new partnerships and continued research. Main push comes from recent regulatory progress, wider distribution, and more money going into new projects. But the company still faces regulatory risk, rivals, funding questions, and tough broader markets as a small-cap. Investors are tracking news on commercial deals and the next round of regulatory news that could move the stock again.
Go toTop